More on KRYS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-30.8% Growth)
- Ratings (9.4 Score)
- Holders

Upcoming Events

- Earnings (11/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Krystal Biotech (NQ:KRYS)
Delayed: 311.50 --0 (-0%)
Prev. Close $311.50  
Open$311.50 
52 Wk High$ 
52 Wk Low$ 
Day High$311.50 
Day Low$311.50 
P/E N/A  
EPS$ 
Volume16 

Friends, Peers and Foes (?): PVLA, AVNS, TMHC, TPC, VVX (more...)

Oct 22, 2026 08:01 AM Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
Oct 15, 2026 01:09 PM Krystal Biotech (KRYS) PT Raised to $416 at Citi
Oct 15, 2026 07:02 AM Form 8-K Krystal Biotech, Inc. For: Oct 15
Oct 15, 2026 07:01 AM Krystal Biotech reports KB113 lesion regression data in Gorlin syndrome
Oct 15, 2026 07:00 AM Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
Sep 24, 2026 05:00 AM Goldman Sachs Assumes Krystal Biotech (KRYS) at Buy
Sep 16, 2026 08:05 PM Form 4 Krystal Biotech, Inc. For: Sep 14 Filed by: ROSSI DINO A
Sep 16, 2026 08:03 PM Form 4 Krystal Biotech, Inc. For: Sep 14 Filed by: Sutherland Everett Rand
Sep 16, 2026 08:02 PM Form 4 Krystal Biotech, Inc. For: Sep 14 Filed by: Mazzacco Catherine
Sep 16, 2026 08:02 PM Form 4 Krystal Biotech, Inc. For: Sep 14 Filed by: Mason Christopher
View All Articles

Entities mentioned with KRYS

View All Entities